GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Destiny Pharma PLC (LSE:DEST) » Definitions » 5-Year Yield-on-Cost %

Destiny Pharma (LSE:DEST) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 13, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Destiny Pharma 5-Year Yield-on-Cost %?

Destiny Pharma's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Destiny Pharma's 5-Year Yield-on-Cost % or its related term are showing as below:



LSE:DEST's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.84
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Destiny Pharma's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Destiny Pharma's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Destiny Pharma's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Destiny Pharma's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Destiny Pharma's 5-Year Yield-on-Cost % falls into.



Destiny Pharma 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Destiny Pharma is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Destiny Pharma  (LSE:DEST) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Destiny Pharma 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Destiny Pharma's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Destiny Pharma (LSE:DEST) Business Description

Traded in Other Exchanges
Address
Unit 36, Sussex Innovation Centre, Science Park Square, Falmer, Brighton, GBR, BN1 9SB
Destiny Pharma PLC is a clinical-stage biotechnology company which is focused on the development of medicines for the treatment of infectious disease. It is developing drugs for the prevention and treatment of infections caused by Antibiotic-Resistant (AR) bacteria. It is involved in developing XF-73 Dermal for the treatment of skin infections of antibiotic-resistant bacteria, XF-73 Nasal for prevention of post-surgical staphylococcal infection, XF Throat for prevention of staphylococcal hospital/ventilator-associated pneumonia infection.

Destiny Pharma (LSE:DEST) Headlines

No Headlines